✦ LIBER ✦

Effect of recombinant activated factor VII on perioperative blood loss in patients undergoing retropubic prostatectomy: a double-blind placebo-controlled randomised trial

✍ Scribed by Philip W Friederich; Christiaan P Henny; Embert J Messelink; Mark G Geerdink; Tymen Keller; Karl-Heinz Kurth; Harry R Büller; Marcel Levi

Book ID: 117282718
Publisher: The Lancet
Year: 2003
Tongue: English
Weight: 92 KB
Volume: 361
Category: Article
ISSN: 0140-6736
DOI: 10.1016/s0140-6736(03)12268-4

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Safety and hemostatic effect of recombin

Safety and hemostatic effect of recombinant activated factor VII in cirrhotic patients undergoing partial hepatectomy: a multicenter, randomized, double-blind, placebo-controlled trial

✍ Yong-Fu Shao; Jia-Mei Yang; Gar-Yang Chau; Yongyut Sirivatanauksorn; Shou-Xian Z 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 78 KB

Efficacy of activated recombinant factor

Efficacy of activated recombinant factor VII (RFVIIA; Novoseven®) in cirrhotic patients with upper gastrointestinal bleeding: A randomised placebo-controlled double-blind multicenter trial

✍ D. Thabut; R. de Franchis; F. Bendtsen; G. D'Amico; A. Albillos; J.G. Abraldes; 📂 Article 📅 2003 🏛 Elsevier Science 🌐 English ⚖ 92 KB

Effect of tesofensine on bodyweight loss

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

✍ Arne Astrup; Sten Madsbad; Leif Breum; Thomas J Jensen; Jens Peter Kroustrup; Th 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 164 KB

Effect of tesofensine on bodyweight loss

Effect of tesofensine on bodyweight loss, body composition, and quality of life in obese patients: a randomised, double-blind, placebo-controlled trial

✍ Arne Astrup; Sten Madsbad; Leif Breum; Thomas J Jensen; Jens Peter Kroustrup; Th 📂 Article 📅 2008 🏛 The Lancet 🌐 English ⚖ 164 KB

Therapeutic effect of recombinant human

Therapeutic effect of recombinant human epidermal growth factor (rhEGF) on mucositis in patients undergoing radiotherapy, with or without chemotherapy, for head and neck cancer : A double-blind placebo-controlled prospective phase 2 multi-institutional clinical trial

✍ Hong Gyun Wu; Si Yeol Song; Yeon Sil Kim; Young Taek Oh; Chang Geol Lee; Ki Chan 📂 Article 📅 2009 🏛 John Wiley and Sons 🌐 English ⚖ 356 KB 👁 2 views

A Randomised Double-blind Placebo-contro

A Randomised Double-blind Placebo-controlled Trial to Determine the Effect of Cranberry Juice on Decreasing the Incidence of Urinary Symptoms and Urinary Tract Infections in Patients Undergoing Radiotherapy for Cancer of the Bladder or Cervix

✍ C.C. Cowan; C. Hutchison; T. Cole; S.J.E. Barry; J. Paul; N.S. Reed; J.M. Russel 📂 Article 📅 2012 🏛 Elsevier Science 🌐 English ⚖ 228 KB